✨ Free AI Report
Merck KGaA: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Merck KGaA
Company Research

Merck KGaA: Business Overview, Financials & Competitive Analysis

Merck KGaA scores 7/10 on the AskCyborg Cyborg Score (Solid). Diversified science and technology leader with steady revenue growth and strategic partnerships positioning it for continued expansion in high-growth pharmaceutical and semiconductor markets. In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. The company maintains diversified revenue streams across healthcare.

What is Merck KGaA's industry? Merck KGaA (merck.com) operates in Pharmaceutical Manufacturing & Life Sciences. AskCyborg classifies Merck KGaA under Pharmaceutical Manufacturing & Life Sciences in its company registry.

Merck KGaA is a Germany-based science and technology company operating in three business segments: Healthcare, Life Sciences and Electronics. Founded in 1668 and headquartered in Darmstadt, Germany, the company serves...

7/ 10Solid

Cyborg Score thesis

Diversified science and technology leader with steady revenue growth and strategic partnerships positioning it for continued...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing & Life Sciences
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Merck KGaA Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Merck KGaA

AskCyborg analysts argue the bull and bear cases for Merck KGaA across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Merck KGaA OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Merck KGaA Overview

Pro stress-test →

Merck KGaA is a Germany-based science and technology company operating in three business segments: Healthcare, Life Sciences and Electronics. Founded in 1668 and headquartered in Darmstadt, Germany, the company serves global markets across pharmaceuticals, life science tools, and semiconductor materials.

Strategic Profile

Pro stress-test →

The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, cardiovascular, metabolism, and endocrinology disorders. The Electronics segment supplies materials comprising thin films, patterning and planarization formulations, specialty gases, optronics, and optical metrology equipment for the semiconductor and display industries. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector.

Competitive Landscape

Pro stress-test →

Merck KGaA operates as a science and technology company competing across Life Science, Healthcare, and Electronics segments. Key competitors include Roche and Novartis in pharmaceuticals, Avantor and Thermo Fisher Scientific in life sciences, and Tokyo Electron and ASML in semiconductor equipment.

Industry Context

Merck KGaA operates in Pharmaceutical Manufacturing & Life Sciences.

Key facts

Founded: 1668 · Headquarters: Darmstadt, Germany · Employees: 62,346 · Revenue: $21.16B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Merck KGaA.

  • Merck KGaA agreed to use Boston-based Valo Health's drug research services in a collaboration focused on Parkinson's and related diseases that is potentially worth over $3 billion.
  • The company has in-licensing agreements with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Valo Health collaboration for Parkinson's research valued at over $3 billion
  • January 2026JP Morgan and Kepler Capital maintained Buy ratings with price targets raised
  • +1 moreTrack every material event for Merck KGaA as it happens. Explore monitoring →
Get alerted when Merck KGaA has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

KeytrudaCancer immunotherapy drug→EMD SeronoSpecialty pharmaceuticals in allergies, fertility, oncology→Roche PharmaOncology and diagnostics→Novartis PharmaceuticalsOncology and specialty care→

Compare Merck KGaA with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Merck KGaA operates in Pharmaceutical Manufacturing & Life Sciences. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing & Life Sciences research →
NEW · MCP server

Ask your AI assistant about Merck KGaA

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Merck KGaA and its top competitor on Cyborg Score”
“What did Merck KGaA do this quarter?”
“Is Merck KGaA a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Merck KGaA do?+
Merck KGaA is a Germany-based science and technology company operating in three business segments: Healthcare, Life Sciences and Electronics. Founded in 1668 and headquartered in Darmstadt, Germany, the company serves...
What is Merck KGaA's Cyborg Score?+
Merck KGaA has a Cyborg Score of 7/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Merck KGaA's main competitors?+
Named competitors include Keytruda, EMD Serono, Roche Pharma, Novartis Pharmaceuticals. The full competitive landscape is in the AskCyborg report.
How can I get the full Merck KGaA research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Merck KGaA research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Merck KGaA over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.